Literature DB >> 22269605

Inflammatory factors in major and macular branch retinal vein occlusion.

Hidetaka Noma1, Hideharu Funatsu, Tatsuya Mimura, Shuichiro Eguchi, Katsunori Shimada.   

Abstract

Concentrations of inflammatory factors were measured in 40 patients with macular edema due to major branch retinal vein occlusion (BRVO) or macular BRVO who were treated by pars plana vitrectomy. Vitreous fluid levels of vascular endothelial growth factor (VEGF), soluble intercellular adhesion molecule-1 (sICAM-1), and pigment epithelium-derived factor (PEDF) were determined. Visual acuity and central macular thickness were significantly improved at 6 months in both groups. Vitreous fluid levels of VEGF and sICAM-1 were higher in the major BRVO group than the macular BRVO group, while the PEDF level was lower in the major group than the macular group. The mean visual acuity and central macular thickness at 6 months were not significantly different between the macular and major groups. In conclusion, patients with major BRVO had higher vitreous levels of inflammatory factors and lower vitreous levels of anti-inflammatory PEDF. Accordingly, regulating inflammatory factors might be more important in major BRVO than macular BRVO.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22269605     DOI: 10.1159/000335047

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  10 in total

1.  Penetration force, geometry, and cutting profile of the novel and old Ozurdex needle: the MONO study.

Authors:  Carsten H Meyer; Zengping Liu; Christian K Brinkmann; Eduardo B Rodrigues; Thomas Bertelmann
Journal:  J Ocul Pharmacol Ther       Date:  2014-05-06       Impact factor: 2.671

2.  Inflammation in retinal vein occlusion.

Authors:  Avnish Deobhakta; Louis K Chang
Journal:  Int J Inflam       Date:  2013-04-03

3.  Long-term outcome after vitrectomy for macular edema with retinal vein occlusion dividing into the occlusion site.

Authors:  Takeshi Iwase; Brian C Oveson
Journal:  J Ophthalmol       Date:  2014-10-13       Impact factor: 1.909

Review 4.  Cytokines and the Pathogenesis of Macular Edema in Branch Retinal Vein Occlusion.

Authors:  Hidetaka Noma; Kanako Yasuda; Masahiko Shimura
Journal:  J Ophthalmol       Date:  2019-05-02       Impact factor: 1.909

5.  Aqueous Fibronectin Correlates With Severity of Macular Edema and Visual Acuity in Patients With Branch Retinal Vein Occlusion: A Proteome Study.

Authors:  Lasse Jørgensen Cehofski; Kentaro Kojima; Nobuhiro Terao; Koji Kitazawa; Sasikala Thineshkumar; Jakob Grauslund; Henrik Vorum; Bent Honoré
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-12-01       Impact factor: 4.799

Review 6.  A Review of Intraocular Biomolecules in Retinal Vein Occlusion: Toward Potential Biomarkers for Companion Diagnostics.

Authors:  Bingjie Wang; Xiao Zhang; Huan Chen; Adrian Koh; Chan Zhao; Youxin Chen
Journal:  Front Pharmacol       Date:  2022-04-26       Impact factor: 5.988

7.  Effect of a Dexamethasone Implant on Rheological Blood Parameters in Patients Treated for Retinal Vein Thrombosis.

Authors:  Dorota Śpiewak; Anna Heinke; Katarzyna Michalska-Małecka
Journal:  Int J Gen Med       Date:  2022-08-30

8.  Foveal sensitivity and morphology in major and macular branch retinal vein occlusion.

Authors:  Hidetaka Noma; Katsunori Shimada; Tatsuya Mimura
Journal:  Open Ophthalmol J       Date:  2012-11-30

9.  Peripheral fluorescein angiographic findings in fellow eyes of patients with branch retinal vein occlusion.

Authors:  Irena Tsui; Asima Bajwa; Valentina Franco-Cardenas; Carolyn K Pan; Hanna Y Kim; Steven D Schwartz
Journal:  Int J Inflam       Date:  2013-03-31

10.  Correlation of inflammatory and proangiogenic cytokines from undiluted vitreous samples with spectral domain OCT scans, in untreated branch retinal vein occlusion.

Authors:  Marcel Pfister; Florian Rothweiler; Martin Michaelis; Jindrich Cinatl; Ralf Schubert; Frank H Koch; Michael J Koss
Journal:  Clin Ophthalmol       Date:  2013-06-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.